Beleggen.nl Markt MonitorMarkt Monitor

Volta Finance 2026

7 Posts
| Omlaag ↓
  1. Arie S 31 december 2025 17:48
    Traditie nieuw draadje 2026
    We beginnen in het nieuwe jaar met € 6,60
    Wordt een mooi jaar voor Volta Finance
  2. forum rang 10 voda 2 januari 2026 11:02
    Volta Finance Limited - Change of Investment Manager

    Volta Finance Limited (VTA / VTAS)
    (the "Company")

    Change of Investment Manager

    Guernsey, 02 January 2026

    The Board of Volta Finance Limited (the "Board") is pleased to announce BNP Paribas Asset Management Europe ("BNP AM") as the Company's new investment manager.

    The appointment of BNP AM is effective as of 31 December 2025 and follows the completion of the merger of AXA Investment Managers Paris ("AXA IM") and BNP AM, pursuant to which BNP AM (as the successor entity to AXA IM) has succeeded to the Company's existing investment management agreement ("IMA").

    The terms of the IMA, including the level of fees payable by the Company, remain unchanged and the Board does not anticipate that any material changes will be made to the Company’s current management arrangements.

    For further information, please contact:

    BNP PARIBAS ASSET MANAGEMENT EUROPE

    Head office:
    1 boulevard Haussmann - 75009 Paris.
    Mailing address:
    Tour Majunga La Défense 9 –
    6 place de la Pyramide –
    92908 PARIS –

    La Défense cedex.
  3. vosco2015 9 januari 2026 09:28
    quote:

    voda schreef op 2 januari 2026 11:02:

    Volta Finance Limited - Change of Investment Manager

    Volta Finance Limited (VTA / VTAS)
    (the "Company")

    Change of Investment Manager

    Guernsey, 02 January 2026

    The Board of Volta Finance Limited (the "Board") is pleased to announce BNP Paribas Asset Management Europe ("BNP AM") as the Company's new investment manager.

    The appointment of BNP AM is effective as of 31 December 2025 and follows the completion of the merger of AXA Investment Managers Paris ("AXA IM") and BNP AM, pursuant to which BNP AM (as the successor entity to AXA IM) has succeeded to the Company's existing investment management agreement ("IMA").

    The terms of the IMA, including the level of fees payable by the Company, remain unchanged and the Board does not anticipate that any material changes will be made to the Company’s current management arrangements.

    For further information, please contact:

    BNP PARIBAS ASSET MANAGEMENT EUROPE

    Head office:
    1 boulevard Haussmann - 75009 Paris.
    Mailing address:
    Tour Majunga La Défense 9 –
    6 place de la Pyramide –
    92908 PARIS –

    La Défense cedex.
    Afwachten wat het nieuwe werkelijk gaat doen.
  4. vosco2015 9 januari 2026 09:30
    Er is in 2015 vier maal dividend betaald, dus er is voldoende geld in het bedrijf. Geeft een klein beetje vertrouwen in 2026 dat er ook wat gaat komen.
  5. forum rang 10 voda 22 januari 2026 17:22
    quote:

    vosco2015 schreef op 9 januari 2026 09:30:

    Er is in 2015 vier maal dividend betaald, dus er is voldoende geld in het bedrijf. Geeft een klein beetje vertrouwen in 2026 dat er ook wat gaat komen.
    Hier een dividend overzicht vanaf 2015.

    Bron: www.dividendinfo.nl/volta-finance
  6. forum rang 10 voda 28 januari 2026 18:05
    Volta Finance Limited (VTA / VTAS)
    December 2025 monthly report

    NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES

    Guernsey, January 28th 2026

    BNPP AM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for December 2025. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).

    Performance and Portfolio Activity

    Dear Investors,

    Volta Finance posted a net return of +0.3% for the final month of the year, taking the year-to-date performance to +2.7%. For comparison, US High Yield bonds returned +8.5%*** and Euro High Yield bonds achieved +5.2% over the same period, while the Morningstar Leveraged Loan indices were up +5.9%*** in the US and +4.1% in Europe.

    December markets were shaped by cautious central banks and mixed macro signals. In the US, the FED cut interest rates by 25bps as expected although it also reinforced its data-dependent stance, signaling patience on rate cuts as services inflation stayed sticky and labor markets cooled gradually. The ECB leaned dovish, highlighting weak growth and easing wage pressures. In the UK, while the Bank of England balanced slowing activity against still-elevated core inflation, one more cut in interest rates was voted and lowered rates from 4% to 3.75%. In Japan, the BOJ continued incremental normalization amid fragile consumption. Globally, softer PMIs contrasted with resilient consumption, while China’s targeted stimulus supported stabilization. Bond yields drifted lower, equities were range-bound, and currencies reflected relative policy divergence.

    Turning to loans, the Morningstar LSTA Leveraged Loan Indices recorded returns of +0.65% in the US*** and +0.48% in Europe, broadly in line with the performance of November. Pricewise, Euro Loans closed around 20 cent up while US Loans were flat through the month. Looking at the CLO markets, a heavy end of year pipeline impacted Non-Investment Grade & Equity as those tranches continued to trade weaker amidst a lack of support and probably some investor fatigue after a busy year.

    Volta Finance flagged this as a buying opportunity and selectively picked up some risk. The Portfolio Managers added €6.0 million worth of new investments, leveraging both the new issue and the secondary markets in a bid to complement shorter duration profiles with longer duration ones. Single-B rated risk was purchased at a discount margin of +925bps (European CLOs), a very attractive level especially considering the strong spread tightening momentum observed since early January. A BB-rated position was also added in the +585bps, offering a decent carry opportunity and a lower duration profile. The fund generated about €25 million in cashflow, which is about 19% of December’s NAV on an annualized basis.

    In terms of performance breakdown, Volta’s CLO Equity tranches returned -0.2%** while CLO Debt tranches returned +0.9% performance**.

    As of end of December 2025, Volta’s NAV* was €259.3m, i.e. €7.09 per share.

    *It should be noted that approximately 0.15% of Volta’s NAV comprises investments for which the relevant NAVs as at the month-end date are normally available only after Volta’s NAV has already been published. Volta’s policy is to publish its NAV on as timely a basis as possible to provide shareholders with Volta’s appropriately up-to-date NAV information. Consequently, such investments are valued using the most recently available NAV for each fund or quoted price for such subordinated notes. The equivalent % proportions of Volta’s NAV as of 30 November and 30 September were 0.07% and 0.08%, respectively.

    ** “performances” of asset classes are calculated as the Dietz-performance of the assets in each bucket, taking into account the Mark-to-Market of the assets at period ends, payments received from the assets over the period, and ignoring changes in cross-currency rates. Nevertheless, some residual currency effects could impact the aggregate value of the portfolio when aggregating each bucket.

    *** These figures are presented in USD. Source: BNPP AM – Bloomberg – Morningstar – December 31st, 2025
  7. forum rang 10 voda 4 februari 2026 08:11
    Director/PDMR Shareholding

    Volta Finance Limited (VTA/VTAS)

    Notification of transactions by directors, persons discharging managerial
    responsibilities and persons closely associated with them

    NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

    *****

    Guernsey,4 February 2026

    Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees and in line with the Company’s current Remuneration Policy, Volta Finance Limited (the “Company” or “Volta”) has purchased 4,401 ordinary shares of no par value in the Company (“Ordinary Shares”) at an average price of €6.64 per share.

    Each director receives 30% of their Director’s fees for any year in the form of shares, which they are required to retain for a period of no less than one year from their respective date of issue.

    The shares will be issued to the Directors, who for the purposes of Regulation (EU) No 596/2014 on Market Abuse ("MAR") are "persons discharging managerial responsibilities" (a "PDMR").

    Dagmar Kershaw, Chairman and a PDMR for the purposes of MAR, acquired 1,242 additional Ordinary Shares in the Company. Following the settlement of this transaction, Ms Kershaw will have an interest in 38,369 Ordinary Shares, representing 0.10% of the issued shares of the Company;

    Stephen Le Page, (Director to 4 December 2025) acquired 321 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mr Le Page will have an interest in 54,586 Ordinary Shares, representing 0.15% of the issued shares of the Company;

    Yedau Ogoundele, Director and a PDMR for the purposes of MAR acquired 869 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mrs Ogoundele will have an interest in 11,434 Ordinary Shares, representing 0.03% of the issued shares of the Company;

    Joanne Peacegood, Director and a PDMR for the purposes of MAR acquired 1,055 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mrs Peacegood will have an interest in 9,056 Ordinary Shares, representing 0.02% of the issued shares of the Company; and

    Simon Holden, Director and a PDMR for the purposes of MAR acquired 914 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mr Holden will have an interest in 2,253 Ordinary Shares, representing 0.01% of the issued shares of the Company.

    The notifications below, made in accordance with the requirements of MAR, provide further detail in relation to the above transactions:

    Zie ook bijlage voor meer:
7 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 467 7.789
AB InBev 3 5.635
Abionyx Pharma 2 29
Ablynx 43 13.357
ABN AMRO 1.583 55.563
ABO-Group 1 29
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 268
Accsys Technologies 24 12.619
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 205
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 15 20.244
Aedifica 3 1.044
Aegon 3.259 324.951
AFC Ajax 538 7.132
Affimed NV 2 6.358
ageas 5.845 109.985
Agfa-Gevaert 15 2.172
Ahold 3.543 74.641
Air France - KLM 1.026 36.007
AIRBUS 1 15
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 469 13.325
Alfen 18 29.577
Allfunds Group 4 1.772
Almunda Professionals (vh Novisource) 651 4.283
Alpha Pro Tech 1 17
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.488 114.842
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.862 253.535
AMG 973 141.473
AMS 3 73
Amsterdam Commodities 307 6.924
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 584
Antonov 22.632 153.607
Aperam 93 15.706
Apollo Alternative Assets 1 17
Apple 5 409
Arcadis 254 9.992
Arcelor Mittal 2.044 322.414
Archos 1 1
Arcona Property Fund 1 305
arGEN-X 18 11.899
Aroundtown SA 1 251
Arrowhead Research 5 9.973
Ascencio 1 39
ASIT biotech 2 697
ASMI 4.109 40.902
ASML 1.769 131.586
ASR Nederland 22 4.622
ATAI Life Sciences 1 7
Atenor Group 1 556
Athlon Group 121 176
Atos 4 3.825
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 36 18.039
Axsome Therapeutics 1 177
Azelis Group 2 28
Azelis Group NV 2 185
Azerion 7 3.857